Table 1.
Study | N | Spectrometer | SF measure | Genotyping platform | Covariates | |
---|---|---|---|---|---|---|
T1D | ||||||
DCCT/EDIC | 1,082 | SCOUT DS | SIF | Illumina 1M | Age, sex, skin tone, clinic latitude, eGFR, smoking status, rs1495741 genotype* | |
WESDR | 281 | SCOUT DS | SIF | Illumina Omni-quad | Age, sex, skin tone, eGFR, smoking status, rs1495741 genotype† | |
ND plus T2D | ||||||
LonGenity | SCOUT DS | SIF | Illumina HumanOmniExpress | Age, sex, skin tone, eGFR, smoking status‡ | ||
ND (OPEL) | 192 | |||||
ND (OPUS) | 261 | |||||
T2D | 58 | |||||
LifeLines | AGE Reader | SAF | Illumina CytoSNP 12v2 | Age, sex, BMI, eGFR, smoking status, 10 first principle components§ | ||
ND | 8,678 | |||||
T2D | 318 |
*Clinic latitude: categorized as a binary variable, with clinic located above 37° N latitude designated as northern clinics. eGFR: mean eGFR trough DCCT/EDIC calculated using annually measured serum creatinine and the Chronic Kidney Disease Epidemiology Collaboration equation (35). Smoking status during EDIC years 1–5, 6–10, and 11–16 as a continuous variable calculated by summing smoking status.
†eGFR: mean eGFR calculated using serum creatinine, measured almost every 5 years, and the Chronic Kidney Disease Epidemiology Collaboration equation (35). Smoking status: mean of smoking status, asked every 5 years through the study.
‡eGFR: eGFR calculated using serum creatinine and the Chronic Kidney Disease Epidemiology Collaboration equation (35). Smoking status: smoker vs. nonsmoker.
§eGFR: Cockcroft-Gault eGFR. Smoking status: smoker vs. nonsmoker.